瑞舒伐他汀与阿托伐他汀治疗血脂异常的临床效果对比[摘 要] 目的：对血脂异常的患者进行瑞舒伐他汀钙片和阿托伐他汀钙片的药物临床治疗，并分析治疗效果。
方法：从患者药物使用后的临床数据标准收集比对、患者药物使用后数据效果收集比对等几个方面综述血脂异常的患者进行瑞舒伐他汀钙片和阿托伐他汀钙片的药物临床治疗，并分析治疗效果的相关理论。
结果：针对血脂异常的患者采取瑞舒伐他汀钙片的药物干预，能够提升患者病症的恢复效率，实现对患者不良反应的情况干预，降低发生不良反应的情况几率，值得在临床中推广。
[关键词] 瑞舒伐他汀钙片；阿托伐他汀钙片；治疗；血脂异常；效果； Abstract: Objective: In this study, patients with dyslipidemia were treated with rosuvastatin calcium tablets and atorvastatin calcium tablets. Clinical efficacy and safety were analyzed. Methods: 120 patients were collected from our hospital from January 2014 to January 2015. 120 patients were randomly divided into 60 patients in the experimental group and 60 in the control group. The interventional treatment of atorvastatin calcium tablets was performed on patients in the control group, and the calcium drug intervention treatment of rosuvastatin was performed on the experimental group. The relevant data were collected to provide scientific support for follow-up study and comparison to achieve clinical efficacy. The full evaluation. Results: Through this study, we found that the clinical efficacy of the experimental group was significantly better than that of the control group. The TC, TG, HDL-C, and LDL-C of the 4th and 8th courses of treatment were the two groups of patients after treatment. The data showed significant differences, while the experimental groups data information was more optimized with the control group. The total effective rate of treatment showed that the experimental group was significantly better than the control group, and there was a statistically significant difference between the two groups (Plt;0.05). for='' the='' two='' groups='' of='' patients='' to='' take='' non-medicine='' treatment='' and='' intervention='' found='' that='' the='' drug='' did='' not='' cause='' adverse='' reactions='' in='' patients.='' conclusion:='' the='' drug='' intervention='' of='' rosuvastatin='' calcium='' tablet='' in='' patients='' with='' dyslipidemia='' can='' improve='' the='' recovery='' efficiency='' of='' patients='' symptoms,='' realize='' the='' intervention='' of='' patients='' adverse='' reactions='' and='' reduce='' the='' incidence='' of='' adverse='' reactions.='' it='' is='' worth='' promoting='' in='' clinical='' practice.='' key='' words:='' rosuvastatin='' calcium='' tablets;='' atorvastatin='' calcium='' tablets;='' treatment;='' dyslipidemia;='' efficacy;='' 一、患者药物使用后的临床数据标准收集比对='' 陈懿,徐世鄂根据研究需要进行相关操作流程的设计和操作，在具体的实施过程当中能够得到相关信息结果，其通过研究能够发现，实验组临床疗效明显优于对照组，两组患者在接受治疗后在第4个疗程和第8个疗程的tc、tg、hdl-c，以及='' ldl-c的数据都呈现出明显的差异，而实验组的数据信息更加优化与对照组[1]。
杨玉玲研究能够发现，实验组患者的治疗效果明显优于对照组。
治疗的总有效率显示，实验组明显优于对照组。
针对两组患者采取不用的药物治疗和干预发现，药物均没有引起患者的不良反应。
通过研究设计的相关流程进行科学的操作和护理干预，可以满足患者实际的临床治疗需求[2]。
='' 二、患者药物使用后数据效果收集比对='' 邵在宏在实验研究中认为两组患者在接受不同的药物治疗和干预的情况下，研究使用的药物都没有影响患者出现不良的反应情况。
以上是毕业论文文献综述，课题毕业论文、任务书、外文翻译、程序设计、图纸设计等资料可联系客服协助查找。
